Clinical Trial Update: A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution

View source ↗

Summary

This clinical trial evaluated long-term pigmentation in the trabecular meshwork after two years of Travatan 0.004% ophthalmic solution for open-angle glaucoma. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma | Status: TERMINATED